Do statins prevent Alzheimer's disease? A narrative review
Homayoun L Daneschvar1, Mark D Aronson2, Gerald W Smetana2
1Harvard Medical School, Division of General Medicine and Primary Care, Beth Israel Deaconess Medical Center/Shapiro 621C, 330 Brookline Ave, Boston, MA 02215, United States.
European Journal of Internal Medicine
|September 7, 2015
Summary
This review explores how cholesterol pathways may influence Alzheimer's disease (AD) and examines the potential of statins (3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors) in preventing or slowing AD progression.
Area of Science:
- Neuroscience
- Pharmacology
- Geriatrics
Background:
- Alzheimer's disease (AD) is the leading cause of dementia in individuals aged 65 and older.
- There is a critical need for interventions to prevent or slow the progression of AD.
- Cholesterol metabolism pathways are implicated in the pathogenesis of AD.
Purpose of the Study:
- To discuss potential pathogenetic pathways of Alzheimer's disease.
- To review existing evidence on the efficacy of statins in preventing or delaying AD progression.
Main Methods:
- Literature review of studies on Alzheimer's disease pathogenesis.
- Analysis of research on the role of cholesterol in AD.
- Evaluation of clinical and preclinical data on statin use for AD prevention.
Main Results:
- Cholesterol-related pathways are increasingly recognized as significant in AD development.
- Statins, inhibitors of HMG-CoA reductase, show promise in preliminary studies for AD prevention.
- Further research is needed to confirm the protective effects of statins against AD.
Conclusions:
- Cholesterol homeostasis may be a key target for AD prevention strategies.
- Statins represent a potential therapeutic avenue for mitigating Alzheimer's disease.
- Evidence suggests statins could play a role in delaying the onset or slowing the progression of Alzheimer's disease.
More Related Videos
09:15Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
15.2K
09:45Motor and Hippocampal Dependent Spatial Learning and Reference Memory Assessment in a Transgenic Rat Model of Alzheimer's Disease with Stroke
Published on: March 22, 2016
10.9K
Related Concept Videos
01:22Alzheimer's Disease: Treatment
1.2K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.2K
01:26Alzheimer's Disease: Overview
2.0K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
2.0K
01:26Atherosclerosis III: Management
589
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
589
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.8K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.8K
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
856
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
856
01:29Cholesterol: Significance and Regulation
1.9K
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
1.9K